Your browser doesn't support javascript.
loading
Genomic epidemiology uncovers the timing and origin of the emergence of mpox in humans.
Parker, Edyth; Omah, Ifeanyi F; Varilly, Patrick; Magee, Andrew; Ayinla, Akeemat Opeyemi; Sijuwola, Ayotunde E; Ahmed, Muhammad I; Ope-Ewe, Oludayo O; Ogunsanya, Olusola Akinola; Olono, Alhaji; Eromon, Philomena; Tomkins-Tinch, Christopher H; Otieno, James Richard; Akanbi, Olusola; Egwuenu, Abiodun; Ehiakhamen, Odianosen; Chukwu, Chimaobi; Suleiman, Kabiru; Akinpelu, Afolabi; Ahmad, Adama; Imam, Khadijah Isa; Ojedele, Richard; Oripenaye, Victor; Ikeata, Kenneth; Adelakun, Sophiyah; Olajumoke, Babatunde; Djuicy, Delia Doreen; Essengue, Loique Landry Messanga; Yifomnjou, Moïse Henri Moumbeket; Zeller, Mark; Gangavarapu, Karthik; O'Toole, Áine; Park, Daniel J; Mboowa, Gerald; Tessema, Sofonias Kifle; Tebeje, Yenew Kebede; Folarin, Onikepe; Happi, Anise; Lemey, Philippe; Suchard, Marc A; Andersen, Kristian G; Sabeti, Pardis; Rambaut, Andrew; Njoum, Richard; Ihekweazu, Chikwe; Jide, Idriss; Adetifa, Ifedayo; Happi, Christian T.
Affiliation
  • Parker E; African Center of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Osun State, Nigeria.
  • Omah IF; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Varilly P; Institute of Ecology and Evolution, University of Edinburgh, The King's Buildings, Edinburgh EH9 3FL, UK.
  • Magee A; Department of Parasitology and Entomology, Nnamdi Azikiwe University, Awka, Nigeria.
  • Ayinla AO; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Sijuwola AE; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Ahmed MI; African Center of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Osun State, Nigeria.
  • Ope-Ewe OO; African Center of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Osun State, Nigeria.
  • Ogunsanya OA; African Center of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Osun State, Nigeria.
  • Olono A; African Center of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Osun State, Nigeria.
  • Eromon P; African Center of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Osun State, Nigeria.
  • Tomkins-Tinch CH; African Center of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Osun State, Nigeria.
  • Otieno JR; African Center of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Osun State, Nigeria.
  • Akanbi O; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Egwuenu A; Theiagen Genomics, Highlands Ranch, CO, USA.
  • Ehiakhamen O; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
  • Chukwu C; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
  • Suleiman K; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
  • Akinpelu A; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
  • Ahmad A; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
  • Imam KI; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
  • Ojedele R; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
  • Oripenaye V; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
  • Ikeata K; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
  • Adelakun S; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
  • Olajumoke B; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
  • Djuicy DD; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
  • Essengue LLM; Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
  • Yifomnjou MHM; Virology Service, Centre Pasteur du Cameroun, 451 Rue 2005, Yaounde 2, P.O. Box 1274.
  • Zeller M; Virology Service, Centre Pasteur du Cameroun, 451 Rue 2005, Yaounde 2, P.O. Box 1274.
  • Gangavarapu K; Virology Service, Centre Pasteur du Cameroun, 451 Rue 2005, Yaounde 2, P.O. Box 1274.
  • O'Toole Á; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Park DJ; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Mboowa G; Institute of Ecology and Evolution, University of Edinburgh, The King's Buildings, Edinburgh EH9 3FL, UK.
  • Tessema SK; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Tebeje YK; Africa Centres for Disease Control and Prevention, P.O. Box 3243, Addis Ababa, Ethiopia.
  • Folarin O; Africa Centres for Disease Control and Prevention, P.O. Box 3243, Addis Ababa, Ethiopia.
  • Happi A; Africa Centres for Disease Control and Prevention, P.O. Box 3243, Addis Ababa, Ethiopia.
  • Lemey P; African Center of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Osun State, Nigeria.
  • Suchard MA; Department of Biological Sciences, Faculty of Natural Sciences, Redeemer's University, Ede, Osun State, Nigeria.
  • Andersen KG; African Center of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Osun State, Nigeria.
  • Sabeti P; Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
  • Rambaut A; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Njoum R; Department of Biomathematics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Ihekweazu C; Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Jide I; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Adetifa I; Scripps Research Translational Institute, La Jolla, CA 92037, USA.
  • Happi CT; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
medRxiv ; 2024 Jun 19.
Article in En | MEDLINE | ID: mdl-38947052
ABSTRACT
Five years before the 2022-2023 global mpox outbreak Nigeria reported its first cases in nearly 40 years, with the ongoing epidemic since driven by sustained human-to-human transmission. However, limited genomic data has left questions about the timing and origin of the mpox virus' (MPXV) emergence. Here we generated 112 MPXV genomes from Nigeria from 2021-2023. We identify the closest zoonotic outgroup to the human epidemic in southern Nigeria, and estimate that the lineage transmitting from human-to-human emerged around July 2014, circulating cryptically until detected in September 2017. The epidemic originated in Southern Nigeria, particularly Rivers State, which also acted as a persistent and dominant source of viral dissemination to other states. We show that APOBEC3 activity increased MPXV's evolutionary rate twenty-fold during human-to-human transmission. We also show how Delphy, a tool for near-real-time Bayesian phylogenetics, can aid rapid outbreak analytics. Our study sheds light on MPXV's establishment in West Africa before the 2022-2023 global outbreak and highlights the need for improved pathogen surveillance and response.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: MedRxiv Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: MedRxiv Year: 2024 Document type: Article Affiliation country: